Citizen Stash Cannabis Corp. (CSCC) is a federally licensed cannabis company focused on distributing high quality cannabis products. With its state-of-the-art facility, ability to source, process, and distribute products nationally, is there opportunity? Plenty.

The underlying reason why investors originally invested in this sector remains the same: cannabis is and will continue to be a thriving multi-billion-dollar industry, with significant growth potential year-over-year.

Financial Reports

Sedar Public Filings

Investor News


Current Markets


Current ($)

24-hour Change ($)

24-hour Change (%)

Why Citizen Stash?


Citizen Stash is the best known as a premium brand in Canada’s legal cannabis market. The Citizen Stash brand was built through proprietary IP and genetics, with a focus on high potency, high quality cannabis flower.


Citizen Stash Cannabis Corp. currently serves 7 provinces and territories, with additional regions coming online in 2021. With this distribution we have built the supply chain and network to support a national brand.


The Citizen Stash model allows us to scale craft efficiently through our co-farming model. This strategy makes us capital efficient with both our supply and inventory, realizing a 405% increase in Q1 2021 vs Q1 2020, and a positive adjusted EBITDA in Q1 2021.


The Citizen Stash opportunity is to be part of a growth model that is highly scalable while operating in a growing market. With the flexibility and nimble nature of the Citizen Stash strategy investors can realize significant growth opportunity with a company that is undervalued to its peers.

Latest Press Releases

Citizen Stash Enters the Province of Nova Scotia

Vancouver, British Columbia, October 12, 2021 Citizen Stash Cannabis Corp. (the “Company“ or “Citizen Stash”) (TSXV:CSC) (OTCQB:EXPFF) (FRANKFURT:MB31) is pleased to announce the launch of its premium flower products into Nova Scotia where it will be available in cannabis retail stores within the province in the coming weeks. The Company’s wholly owned subsidiary, Experion Biotechnologies

Read More »

Citizen Stash completes $1.5 million debenture offering to The Valens Company and files information circular in connection with Arrangement Agreement

Citizen Stash to hold Special Meeting of Securityholders on Monday, November 1, 2021 NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, B.C., October 5, 2021 – Citizen Stash Cannabis Corp. (“Citizen Stash”) (formerly Experion Holdings Ltd.) (TSXV: CSC) (OTCQB: EXPFF) (FRANKFURT: MB31) is pleased to announce

Read More »






Q1 Q2 Q3 Q4

Financial Statement

Q1 Q2 Q3 Q4

Public Filings

Leadership Team

Team member Icon

Jarrett Malnarich


Over 20 years of executive management including 10 years leading public companies on various exchanges. Leading rapidly growing companies with extensive experience in various food and beverage, natural health, pharmaceutical and agriculture companies and directly involved in cannabis for over 7 years in Canada and the US.

Team member Icon

Kerry Biggs


Over 23 years finance and business experience, including prior publicly traded CFO experience within the Canadian cannabis sector. Mr. Biggs has also worked at lululemon athletica, where he was Vice President, Treasurer looking after all capital markets, liquidity, treasury, and insurance activities, as well as other senior finance roles at Global Container Terminals (OTPP asset), Finning International and Enbridge Inc.

Team member Icon

Daryn Medwid


Over 20 years of senior management experience in beverage alcohol including Molson-Coors and Diageo and is excited to now bring his skillset into the emerging cannabis space. Well known for his positive leadership style, Mr. Medwid brings an entrepreneurial perspective to the workplace helping transform businesses operations by creating high performing teams guided by a consumer first strategic vision.


For investor relations inquiries or any other questions relating to Citizen Stash Cannabis Corp. please contact investor relations.